Pharmaceutical Supply – Bupivacaine Hydrochloride Injection

The contract pertains to the supply and delivery of three vials of Bupivacaine Hydrochloride Injection, USP, 0.5%, in 50 mL volumes, with all packaging and labeling strictly adhering to FDA, USP, and Department of Defense standards. The order is part of a subcontract under the Medical Supply Chain Pharm FSA, operating under the Department of Defense, and is targeted for performance at APO, ZIP 96213-2166. The solicitation was posted on July 28, 2026, with a response deadline of August 3, 2026, indicating a narrow window for submission. The NAICS code 325412 confirms the classification as pharmaceutical manufacturing, ensuring the supplier must be qualified to meet rigorous pharmaceutical and military compliance requirements. The contract does not specify any set-aside provisions, meaning it is open to all eligible contractors without restriction based on business size or veteran status. All deliveries must satisfy the exacting specifications mandated by federal and defense regulatory bodies to ensure safety, efficacy, and compatibility with military medical logistics systems.